| Publication Type: | Article |
| Journal Name: | New England Journal of Medicine |
| Full Citation: | Darrow, J.J., Avorn, J., Kesselheim, A.S. "New FDA Breakthrough-Drug Category — Implications for Patients." New England Journal of Medicine, 2014; 370:1252-1258. |
| External Link: | New FDA Breakthrough-Drug Category — Implications for Patients |
| Project: | Sources of Transformative Innovation in Medication Development |
| People: | Aaron Kesselheim |